Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Times Interest Earned (2016 - 2019)

Vistagen Therapeutics' Times Interest Earned history spans 8 years, with the latest figure at $3975.3 for Q4 2019.

  • For Q4 2019, Times Interest Earned rose 199.49% year-over-year to $3975.3; the TTM value through Sep 2020 reached $10427.9, up 291.05%, while the annual FY2018 figure was -$1595.5, 28.39% up from the prior year.
  • Times Interest Earned for Q4 2019 was $3975.3 at Vistagen Therapeutics, up from -$3995.7 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $3975.3 in Q4 2019 and bottomed at -$8501.0 in Q1 2016.
  • The 5-year median for Times Interest Earned is -$1664.7 (2017), against an average of -$1927.9.
  • The largest annual shift saw Times Interest Earned tumbled 40614.44% in 2016 before it soared 199.49% in 2019.
  • A 5-year view of Times Interest Earned shows it stood at -$714.0 in 2015, then crashed by 269.33% to -$2637.0 in 2016, then skyrocketed by 45.62% to -$1434.0 in 2017, then plummeted by 178.64% to -$3995.7 in 2018, then soared by 199.49% to $3975.3 in 2019.
  • Per Business Quant, the three most recent readings for VTGN's Times Interest Earned are $3975.3 (Q4 2019), -$3995.7 (Q4 2018), and -$2477.3 (Q3 2018).